Source: Journal of vascular and interventional radiology. Unidade: FM
Subjects: EMBOLIZAÇÃO TERAPÊUTICA, OBSTRUÇÃO URETRAL, INIBIDORES DE ENZIMAS, PRÓSTATA
ABNT
CARDARELLI-LEITE, Leandro et al. Impact of 5-alpha-reductase inhibitors use at the time of prostatic artery embolization for treatment of benign prostatic obstruction. Journal of vascular and interventional radiology, v. 30, n. 2, p. 228-232, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jvir.2018.11.027. Acesso em: 19 ago. 2024.APA
Cardarelli-leite, L., Assis, A. M. de, Moreira, A. M., Antunes, A. A., Cerri, G. G., Srougi, M., & Carnevale, F. C. (2019). Impact of 5-alpha-reductase inhibitors use at the time of prostatic artery embolization for treatment of benign prostatic obstruction. Journal of vascular and interventional radiology, 30( 2), 228-232. doi:10.1016/j.jvir.2018.11.027NLM
Cardarelli-leite L, Assis AM de, Moreira AM, Antunes AA, Cerri GG, Srougi M, Carnevale FC. Impact of 5-alpha-reductase inhibitors use at the time of prostatic artery embolization for treatment of benign prostatic obstruction [Internet]. Journal of vascular and interventional radiology. 2019 ; 30( 2): 228-232.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1016/j.jvir.2018.11.027Vancouver
Cardarelli-leite L, Assis AM de, Moreira AM, Antunes AA, Cerri GG, Srougi M, Carnevale FC. Impact of 5-alpha-reductase inhibitors use at the time of prostatic artery embolization for treatment of benign prostatic obstruction [Internet]. Journal of vascular and interventional radiology. 2019 ; 30( 2): 228-232.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1016/j.jvir.2018.11.027